Published in Semin Oncol Nurs on August 01, 2009
Patient navigation: an update on the state of the science. CA Cancer J Clin (2011) 3.26
Metrics for evaluating patient navigation during cancer diagnosis and treatment: crafting a policy-relevant research agenda for patient navigation in cancer care. Cancer (2011) 1.13
Experiences of women of color with a nurse patient navigation program for linkage and engagement in HIV care. AIDS Patient Care STDS (2014) 0.95
Benefits and challenges perceived by patients with cancer when offered a nurse navigator. Int J Integr Care (2011) 0.93
Randomized controlled trial of patient navigation for newly diagnosed cancer patients: effects on quality of life. Cancer Epidemiol Biomarkers Prev (2012) 0.93
Stepped care targeting psychological distress in head and neck and lung cancer patients: a randomized clinical trial. BMC Cancer (2012) 0.91
Gynecological cancer patients' differentiated use of help from a nurse navigator: a qualitative study. BMC Health Serv Res (2012) 0.86
Effectiveness of nurse case management compared with usual care in cancer patients at a single medical center in Taiwan: a quasi-experimental study. BMC Health Serv Res (2013) 0.80
The development and implementation of a volunteer lay navigation competency framework at an outpatient cancer center. Support Care Cancer (2014) 0.79
Cancer care coordinators in stage III colon cancer: a cost-utility analysis. BMC Health Serv Res (2015) 0.75
Nurse navigation is helpful for cancer patients, but with some restrictions. EJC Suppl (2013) 0.75
Cancer risks attributable to low doses of ionizing radiation: assessing what we really know. Proc Natl Acad Sci U S A (2003) 7.44
A functional genomic fingerprint of chronic stress in humans: blunted glucocorticoid and increased NF-kappaB signaling. Biol Psychiatry (2008) 3.08
Breast cancer and abortion: collaborative reanalysis of data from 53 epidemiological studies, including 83?000 women with breast cancer from 16 countries. Lancet (2004) 2.80
Insulin-like growth factors, their binding proteins, and prostate cancer risk: analysis of individual patient data from 12 prospective studies. Ann Intern Med (2008) 2.33
Residential radon and lung cancer--detailed results of a collaborative analysis of individual data on 7148 persons with lung cancer and 14,208 persons without lung cancer from 13 epidemiologic studies in Europe. Scand J Work Environ Health (2006) 2.18
PSA screening and prostate cancer mortality. CMAJ (2002) 1.98
Systematic review of the literature on characteristics of late-talking toddlers. Int J Lang Commun Disord (2008) 1.72
Health-related quality of life as a survival predictor for patients with localized head and neck cancer treated with radiation therapy. J Clin Oncol (2009) 1.70
Antihypertensive drug use and the risk of prostate cancer (Canada). Cancer Causes Control (2004) 1.63
The mortality of doctors in relation to their smoking habits: a preliminary report. 1954. BMJ (2004) 1.35
Effect of treatment delay on outcome of patients with early-stage head-and-neck carcinoma receiving radical radiotherapy. Int J Radiat Oncol Biol Phys (2002) 1.22
Antioxidant vitamin and mineral supplementation and prostate cancer prevention in the SU.VI.MAX trial. Int J Cancer (2005) 1.19
Interaction between antioxidant vitamin supplementation and cigarette smoking during radiation therapy in relation to long-term effects on recurrence and mortality: a randomized trial among head and neck cancer patients. Int J Cancer (2008) 1.18
Quality of life in a randomized trial of group psychosocial support in metastatic breast cancer: overall effects of the intervention and an exploration of missing data. J Clin Oncol (2003) 1.17
Development and validation of a psychosocial screening instrument for cancer. Health Qual Life Outcomes (2005) 1.17
Randomized controlled trial of Mindfulness-based cancer recovery versus supportive expressive group therapy for distressed survivors of breast cancer. J Clin Oncol (2013) 1.13
Dosage, duration and timing of nonsteroidal antiinflammatory drug use and risk of prostate cancer. Int J Cancer (2003) 1.06
Predictors of severe acute and late toxicities in patients with localized head-and-neck cancer treated with radiation therapy. Int J Radiat Oncol Biol Phys (2011) 1.04
Predictors of weight loss during radiotherapy in patients with stage I or II head and neck cancer. Cancer (2010) 1.03
Genetic polymorphisms and head and neck cancer outcomes: a review. Cancer Epidemiol Biomarkers Prev (2008) 1.02
p53 and Ki-67 as markers of radioresistance in head and neck carcinoma. Cancer (2002) 1.02
Professional navigation framework: elaboration and validation in a Canadian context. Oncol Nurs Forum (2012) 1.01
Serum prognostic markers in head and neck cancer. Clin Cancer Res (2010) 1.01
Implementing the role of patient-navigator nurse at a university hospital centre. Can Oncol Nurs J (2006) 1.00
Role of immunohistochemical overexpression of matrix metalloproteinases MMP-2 and MMP-11 in the prognosis of death by ovarian cancer. Am J Clin Pathol (2008) 1.00
Understanding Canadian Punjabi-speaking South Asian women's experience of breast cancer: a qualitative study. Int J Nurs Stud (2006) 0.98
Educational needs of palliative care nurses in Quebec. J Palliat Care (2005) 0.96
The psychosocial screen for cancer (PSSCAN): further validation and normative data. Health Qual Life Outcomes (2009) 0.96
Prognostic significance of lymphovascular invasion in surgically cured rectal carcinoma. Am J Surg (2005) 0.95
A prospective study of the insulin-like growth factor axis in relation with prostate cancer in the SU.VI.MAX trial. Cancer Epidemiol Biomarkers Prev (2005) 0.92
Dietary vitamin D intake and serum 25-hydroxyvitamin D level in relation to disease outcomes in head and neck cancer patients. Int J Cancer (2010) 0.92
Immunohistochemical analysis of possible chemoresistance markers identified by micro-arrays on serous ovarian carcinomas. Mod Pathol (2008) 0.90
Characterization of DOK1, a candidate tumor suppressor gene, in epithelial ovarian cancer. Mol Oncol (2011) 0.89
Trait mindfulness, repression, suppression, and self-reported mood and stress symptoms among women with breast cancer. J Clin Psychol (2012) 0.86
Prognostic significance of cyclooxygenase-2 overexpression in glottic cancer. Clin Cancer Res (2008) 0.86
Professional navigation: a comparative study of two Canadian models. Can Oncol Nurs J (2012) 0.86
The impact of acculturation on the use of traditional Chinese medicine in newly diagnosed Chinese cancer patients. Support Care Cancer (2007) 0.85
Impact of a meaning-centered intervention on job satisfaction and on quality of life among palliative care nurses. Psychooncology (2009) 0.85
Validation of genetic sequence variants as prognostic factors in early-stage head and neck squamous cell cancer survival. Clin Cancer Res (2011) 0.84
Genetic sequence variants and the development of secondary primary cancers in patients with head and neck cancers. Cancer (2011) 0.83
Three profiles of language abilities in toddlers with an expressive vocabulary delay: variations on a theme. J Speech Lang Hear Res (2010) 0.83
Acute adverse effects of radiation therapy and local recurrence in relation to dietary and plasma beta carotene and alpha tocopherol in head and neck cancer patients. Nutr Cancer (2007) 0.82
Genetic sequence variants in vitamin D metabolism pathway genes, serum vitamin D level and outcome in head and neck cancer patients. Int J Cancer (2012) 0.81
A cosmetic evaluation of breast cancer treatment: a randomized study of radiotherapy boost technique. Int J Radiat Oncol Biol Phys (2005) 0.81
Human epididymis protein 4 (HE4) and ovarian cancer prognosis. Gynecol Oncol (2012) 0.81
Factors associated with weight loss during radiotherapy in patients with stage I or II head and neck cancer. Support Care Cancer (2011) 0.81
A structured approach to knowledge exchange: understanding the implementation of a cancer survivor program. Eur J Oncol Nurs (2011) 0.80
Green tea for ovarian cancer prevention and treatment: a systematic review of the in vitro, in vivo and epidemiological studies. Gynecol Oncol (2012) 0.80
A randomized controlled double-masked trial of albuterol add-on therapy in patients with multiple sclerosis. Arch Neurol (2010) 0.79
A two-stage, single-arm, phase II study of EGCG-enriched green tea drink as a maintenance therapy in women with advanced stage ovarian cancer. Gynecol Oncol (2013) 0.79
Core areas of practice and associated competencies for nurses working as professional cancer navigators. Can Oncol Nurs J (2013) 0.77
Cancer survivorship: creating a national agenda. Can Oncol Nurs J (2009) 0.77
A conversation with Sir Richard Doll. Epidemiology (2003) 0.76
Spanish toxic oil syndrome. Med Hist (2003) 0.75
The Knowledge Exchange-Decision Support Model: application to cancer navigation programs. Support Care Cancer (2013) 0.75
[The process of integrating oncology nurse navigators into joint (hospital-community) local teams]. Can Oncol Nurs J (2010) 0.75
Potential funding crisis for the Radiation Effects Research Foundation. Lancet (2004) 0.75
Prostatic intraepithelial neoplasia in TURP specimens and subsequent prostate cancer. Can J Urol (2006) 0.75
Funding crisis at the Radiation Effects Research Foundation. J Radiol Prot (2004) 0.75
Diagnosis and therapy of polycystic ovarian syndrome: results of a survey among German gynecologists with a review on literature. Arch Gynecol Obstet (2011) 0.75
Radiological weapons. Lancet (1982) 0.75